GBS Venture Partners
Australian venture capital firm investing seed to early expansion in unlisted life science companies across therapeutics, diagnostics, medical devices and health IT.
GBS Venture Partners is an Australian venture capital firm that invests in unlisted, high-growth life science technology companies. The firm describes itself as a specialist life science investor, backing companies built on innovative science and technology and supporting entrepreneurs in converting research into businesses. It operates dedicated Australian bioscience and life science venture funds and is based in Melbourne, Australia.
Investments span seed and start-up stages through early expansion, with capital supplemented by operating experience intended to help develop portfolio companies. Its stated areas of focus include human therapeutics, animal therapeutics, diagnostics, medical devices and health information technology, alongside adjacent science-based industries such as agribusiness technology, food technology and environmental technology.
The firm frames its objective as helping talented entrepreneurs build successful life science technology companies, with an emphasis on improving health and other important outcomes. Its investment approach combines funding with value-add support across the development of Australian life science ventures.